Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
Rapamycin and mTORC1 inhibition in the mouse: skin cancer preventionMohammad Athar, Levy KopelovichCell Cycle (Georgetown, Tex.)|August 3, 2013
Heritable one-hit events defining cancer prevention?Levy Kopelovich, Brittney Shea-HerbertOncotarget|September 9, 2017
PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancerRobert I Glazer, Levy KopelovichInternational Journal of Molecular Medicine|September 20, 2002
Efficacy of chemopreventive agents for growth inhibition of Apc [+/-] 1638NCOL colonic epithelial cellsMeena Katdare, Levy Kopelovich, Nitin TelangCurrent Pharmaceutical Design|March 12, 2011
Pharmacological activation of p53 in cancer cellsMohammad Athar, Craig A Elmets, Levy KopelovichJournal of the National Cancer Institute|December 5, 2003
The epigenome as a target for cancer chemopreventionLevy Kopelovich, James A Crowell, Judith R FayExpert Opinion on Therapeutic Targets|June 7, 2005
Targeting epigenetic regulatory mechanisms in cancer chemopreventionJudith R Fay, James A Crowell, Levy KopelovichOncology Reports|October 10, 2003
In vitro evaluation of chemopreventive agents using cultured human prostate epithelial cellsX Steven Wan, Zhoazong Zhou, Ann R Kennedy, et al.Archives of Biochemistry and Biophysics|January 15, 2011
Pathogenesis of nonmelanoma skin cancers in organ transplant recipientsMohammad Athar, Stephanie B Walsh, Levy Kopelovich, et al.Anticancer Research|January 5, 2007
Evaluation of cancer chemopreventive agents using clones derived from a human prostate cancer cell lineJeffrey H Ware, Zhaozong Zhou, Levy Kopelovich, et al.Pageof 15